These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
572 related articles for article (PubMed ID: 15661057)
1. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity. Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057 [TBL] [Abstract][Full Text] [Related]
2. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells. Jagadeesh S; Kyo S; Banerjee PP Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells. Thelen P; Wuttke W; Jarry H; Grzmil M; Ringert RH J Urol; 2004 May; 171(5):1934-8. PubMed ID: 15076315 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma. He H; Xia HH; Wang JD; Gu Q; Lin MC; Zou B; Lam SK; Chan AO; Yuen MF; Kung HF; Wong BC Cancer; 2006 Mar; 106(6):1243-9. PubMed ID: 16444744 [TBL] [Abstract][Full Text] [Related]
5. Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT. Kitagawa Y; Kyo S; Takakura M; Kanaya T; Koshida K; Namiki M; Inoue M Clin Cancer Res; 2000 Jul; 6(7):2868-75. PubMed ID: 10914736 [TBL] [Abstract][Full Text] [Related]
6. [Role of human telomerase reverse transcriptase in apoptosis of human umbilical vein endothelial cells induced by trichostatin A]. Wu P; Xi L; Chen G; Wang BB; Luo DF; Lu YP; Zhou JF; Ma D Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):334-7. PubMed ID: 17892126 [TBL] [Abstract][Full Text] [Related]
7. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of telomerase with human telomerase reverse transcriptase antisense increases the sensitivity of tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells. Gao XD; Chen YR Asian J Androl; 2007 Sep; 9(5):697-704. PubMed ID: 17712489 [TBL] [Abstract][Full Text] [Related]
9. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro. Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191 [TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect of antisense human telomerase reverse transcriptase(hTERT) on telomerase activity of human pulmonary giant cell carcinoma cell line(PLA-801D)]. Ma XB; Han WD; Hao HJ; Li Q; Xu ZM; Lu XC; Zhao YL Ai Zheng; 2003 Sep; 22(9):932-7. PubMed ID: 12969524 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells. Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348 [TBL] [Abstract][Full Text] [Related]
12. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression. Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954 [TBL] [Abstract][Full Text] [Related]
13. [Effect of telomerase on ginsenoside Rh2-induced differentiation of hepatocarcinoma cell line SMMC-7721]. Zeng XL; Tu ZG Ai Zheng; 2004 Dec; 23(12):1655-9. PubMed ID: 15601555 [TBL] [Abstract][Full Text] [Related]
14. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines]. Song Y; Kong BH; Liu PS; Ma DX; Jiang S Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708 [TBL] [Abstract][Full Text] [Related]
15. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo]. Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435 [TBL] [Abstract][Full Text] [Related]
16. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours. Schneider-Stock R; Boltze C; Jäger V; Epplen J; Landt O; Peters B; Rys J; Roessner A J Pathol; 2003 Apr; 199(4):517-25. PubMed ID: 12635143 [TBL] [Abstract][Full Text] [Related]
17. Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus-16/18-infected lung tumorigenesis. Cheng YW; Wu TC; Chen CY; Chou MC; Ko JL; Lee H Clin Cancer Res; 2008 Nov; 14(22):7173-9. PubMed ID: 19010833 [TBL] [Abstract][Full Text] [Related]
18. Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas. Lin PC; Lin SZ; Chen YL; Chang JS; Ho LI; Liu PY; Chang LF; Harn YC; Chen SP; Sun LY; Huang PC; Chein JT; Tsai CH; Chou CW; Harn HJ; Chiou TW Ann Surg Oncol; 2011 Nov; 18(12):3514-27. PubMed ID: 21553143 [TBL] [Abstract][Full Text] [Related]
19. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts. Liu CM; Lo YC; Tai MH; Wu BN; Wu WJ; Chou YH; Chai CY; Huang CH; Chen IJ Prostate; 2009 May; 69(6):610-23. PubMed ID: 19143029 [TBL] [Abstract][Full Text] [Related]
20. Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription and telomerase activity. Zou L; Zhang P; Luo C; Tu Z Urology; 2006 Jun; 67(6):1335-40. PubMed ID: 16765199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]